Detalhe da pesquisa
1.
Safety, tolerability, pharmacokinetic, pharmacodynamic and immunogenicity profiles of Exendin-4-IgG4-Fc in healthy subjects: A phase 1, single-centre, randomized, double-blind, dose escalation study.
Diabetes Obes Metab
; 26(4): 1395-1406, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38287130
2.
Pharmacokinetics, Safety, and Immunogenicity of Intravenous and Subcutaneous Single-Dose QX002N Injection in Healthy Subjects: A Randomized, Open, Parallel, Single-Center, Phase I Study.
Rheumatol Ther
; 2024 Jun 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38853228
3.
Safety and immunogenicity of primary vaccination with a SARS-CoV-2 mRNA vaccine (SYS6006) in Chinese participants aged 18 years or more: Two randomized, observer-blinded, placebo-controlled and dose-escalation phase 1 clinical trials.
Hum Vaccin Immunother
; 19(3): 2285089, 2023 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38111106
4.
Phase I study of a non-S2P SARS-CoV-2 mRNA vaccine LVRNA009 in Chinese adults.
Vaccine
; 41(48): 7297-7306, 2023 11 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37925316